LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 24 Apr 2025
Drug Safety Update

Short

Published on 24 Apr 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with or without anti-inflammatory maintenance therapy in…
Drug Safety Update on GOV.UK ↗ All events: Short

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with or without anti-inflammatory maintenance therapy in patients with asthma. Healthcare professionals should be aware of the change in guidance that no longer recommends prescribing SABA without an inhaled corticosteroid.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.